Intravascular Stents Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Product (Coronary Stents, Peripheral Stents), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIntravascular Stents Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Product (Coronary Stents, Peripheral Stents), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 11.98 Billion |
| CAGR (2024-2029) | 7.30% |
| Fastest Growing Segment | Hospitals & Clinics |
| Largest Market | North America |
| Market Size (2029) | USD 18.20 Billion |
Market Overview
Global Intravascular Stents Market was valued at USD 11.98 Billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 7.30% through 2029.
The global aging population is more prone to cardiovascular diseases. As the elderly population increases, so does the demand for intravascular stents.
Key Market Drivers
Technological Advancements
Drug-eluting stents are coated with medications that are slowly released to inhibit tissue regrowth and reduce restenosis (re-narrowing of the treated vessel). The development of various drug coatings, such as sirolimus and paclitaxel, has significantly improved the long-term efficacy of stents in preventing restenosis. Bioabsorbable stents are designed to gradually dissolve in the body over time, leaving behind only natural tissue. These stents eliminate some of the long-term issues associated with metallic stents, such as the risk of late stent thrombosis and potential interference with future procedures or imaging.
Hybrid stent designs combine the benefits of both balloon-expandable and self-expanding stents. These stents provide precise deployment and radial strength while also adapting to vessel anatomy. Some DES now use bioresorbable polymer coatings to release drugs. These coatings are absorbed by the body over time, reducing the risk of chronic inflammation and long-term complications. 3D printing technology is being used to create patient-specific stents tailored to an individual's unique vascular anatomy. This can lead to more effective and personalized treatment. Nanotechnology is being employed to improve the biocompatibility of stents, allowing for better integration with vascular tissue and reduced inflammation. Radiopaque stents are designed to be highly visible under fluoroscopy, aiding in precise placement. Radiolucent stents are transparent under X-ray, enabling better visualization of vessel structures. Advancements in coating technologies, such as nano-coatings and bioactive coatings, enhance the release of drugs and improve stent performance.
Reducing the thickness of stent struts minimizes the obstruction to blood flow, reduces the risk of restenosis, and improves deliverability during the procedure. These stents use biodegradable polymers that are gradually absorbed by the body. This technology minimizes long-term inflammation and complications associated with polymer coatings. Innovations in imaging and 3D modeling allow for the creation of stents that precisely match a patient's vascular anatomy, reducing complications and optimizing treatment. These devices combine angioplasty balloons with drug coatings to provide localized drug delivery to the treated area. They are used in conjunction with stents or as an alternative treatment option. The use of advanced materials and alloys, such as nitinol, in stent construction allows for improved flexibility, conformability, and durability. Stent manufacturers are exploring the integration of sensors into stents, enabling remote monitoring of stent performance and patient condition. This factor will help in the development of the
Increasing Awareness and Diagnosis
Greater awareness of cardiovascular health and the availability of routine screenings and diagnostic tests have led to the early detection of cardiovascular conditions. This includes coronary artery disease, peripheral artery disease, and other vascular disorders that may require stent implantation. With improved awareness, individuals at risk of cardiovascular diseases are more likely to seek medical attention when they experience symptoms or risk factors. Early intervention can prevent disease progression and may involve the use of intravascular stents.
Timely diagnosis and treatment can reduce the severity of the disease, lower the risk of complications, and improve patient outcomes. Stent placement is often a minimally invasive and effective solution for managing these conditions. Increased awareness often leads to better patient education about cardiovascular diseases and found at treatment options, including stent placement. Informed patients are more likely to participate in their healthcare decisions. Awareness campaigns and improved public knowledge about cardiovascular diseases lead to more referrals from primary care physicians and general practitioners to specialists who may recommend stent procedures when appropriate. Increased awareness encourages individuals to manage modifiable risk factors, such as smoking, unhealthy diet, and sedentary lifestyles, which can contribute to the prevention of cardiovascular diseases and reduce the need for stent interventions.
National and regional health organizations often run screening programs and campaigns that target at-risk populations. These programs lead to increased diagnosis and may result in the use of stents as a treatment option. Global health initiatives, including World Heart Day and World Stroke Day, play a role in raising awareness about the burden of cardiovascular diseases, promoting prevention, and encouraging timely treatment when necessary. Local health departments, clinics, and healthcare organizations often engage in community outreach efforts to educate the public about heart health and the importance of early diagnosis and treatment. Awareness efforts also help reduce the stigma associated with cardiovascular diseases, making it more acceptable for individuals to discuss symptoms and seek treatment. A growing focus on cardiovascular health has led to increased research and innovation in the field of intravascular stents, resulting in more effective and safer stent designs and technologies. This factor will pace up the demand of the
Increasing Aging Population
As individuals age, their risk of developing cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and aortic stenosis, significantly increases. These conditions often require the use of intravascular stents for treatment. Older adults are more likely to have chronic health conditions, such as diabetes, hypertension, and hyperlipidemia, which are risk factors for cardiovascular diseases. These conditions may necessitate the use of stents to manage and treat vascular complications. The aging process is associated with changes in blood vessels, such as atherosclerosis and arterial stiffening, which can lead to vascular obstructions. Stents are commonly used to address these age-related changes. Older patients often have complex medical histories, including prior cardiovascular interventions or comorbid conditions, making stent procedures a valuable treatment option to manage their healthcare needs.
Advances in healthcare and medical treatments have increased life expectancy, resulting in a larger aging population. As individuals live longer, they are more likely to experience age-related cardiovascular issues that may require stent interventions. Older adults are increasingly considered surgical candidates for stent procedures, as advancements in healthcare allow for improved outcomes and safety for elderly patients. The elderly population often prefers minimally invasive procedures like stent placement, as they typically involve shorter recovery times and reduced trauma compared to open surgeries. Aging patients may undergo stent procedures as preventive interventions to address potential blockages or stenoses in their arteries before they lead to severe complications.
Stent placement can allow older adults to maintain an active and independent lifestyle, reducing the impact of cardiovascular conditions on daily activities. Older individuals, particularly in developed countries, have better access to healthcare, including specialized cardiology services that offer stent procedures. The aging population benefits from post-stent care, which helps manage their cardiovascular health and reduce the risk of complications or revascularization procedures. With longer life expectancies, older patients are more inclined to educate themselves about cardiovascular health and the found at treatment options, including stent procedures. This factor will accelerate the demand of the Global Intravascular Stents Market.
Key Market Challenges
Post-Market Surveillance and Reporting
The need for long-term follow-up data to assess the safety and efficacy of intravascular stents is a considerable challenge. Stents are implanted for extended periods, and adverse events or complications may not become evident until years after the procedure. The intravascular stents market serves diverse patient populations with varying risk factors, comorbidities, and anatomical characteristics. This diversity complicates data collection and analysis, making it challenging to draw broad conclusions about stent performance. There is variability in how adverse events and complications are reported and recorded among different healthcare institutions and regions. This can hinder the aggregation and analysis of post-market data. Adverse events associated with stent use may be underreported, either due to lack of awareness or reluctance on the part of healthcare providers or patients. This can lead to incomplete data and an inaccurate assessment of stent safety. Variations in regulatory requirements and post-market surveillance expectations in different countries or regions can complicate the harmonization of data collection and reporting practices. Collating and integrating data from various sources, including electronic health records, clinical studies, and device registries, can be technically challenging, especially in cases where healthcare systems lack interoperability. Stringent patient privacy regulations and concerns can limit the sharing of patient data across institutions and borders, hindering comprehensive post-market surveillance efforts.
Market Saturation
The global intravascular stents market is relatively mature, with a well-established presence of multiple manufacturers and a wide range of stent products. This maturity can limit opportunities for significant growth. Market saturation often leads to intense competition among stent manufacturers, resulting in pricing pressures and reduced profit margins. In mature markets, there may be less room for groundbreaking innovations, as many of the key technological advancements have already been launched. This can limit opportunities for differentiation. Most healthcare facilities, especially in developed regions, are already equipped to perform stent procedures, and many physicians are experienced in stent implantation. This saturation limits the expansion of the customer base. As the market becomes saturated, the overall growth rate may slow down, making it challenging for companies to achieve substantial revenue increases. Fierce competition often leads to price competition, which can impact the profitability of stent manufacturers. Lower prices may be required to gain or maintain market share.
Key Market Trends
Customization and Personalization
Advancements in medical imaging, such as computed tomography (CT), angiography and intravascular ultrasound (IVUS), allow for the creation of patient-specific stents. These stents are designed to match the unique vascular anatomy of each patient, improving the precision and effectiveness of the intervention. 3D printing technology is being used to manufacture stents that are customized to fit individual patients. These stents are designed based on the specific dimensions and geometry of a patient's vessels, potentially reducing complications, and improving stent performance. Personalization extends to the choice of coatings and drugs used in drug-eluting stents (DES). Different patients may respond differently to various coatings and drugs, and the ability to customize these elements can optimize patient outcomes. Customized stent solutions align with the principles of precision medicine, where medical decisions and treatments are tailored to the genetic, molecular, and clinical characteristics of individual patients. Personalization in the intravascular stents market involves assessing an individual patient's risk factors, comorbidities, and specific cardiovascular conditions. This information helps guide stent selection and treatment decisions.
Segmental Insights
Type Insights
Based on Type,
Product Insights
Based on Product,
Regional Insights
Based on Region, North America have emerged as the dominating region in the Global Intravascular Stents Market in 2023. North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. This infrastructure includes state-of-the-art hospitals, well-equipped cardiac care centers, and many skilled healthcare professionals, which are essential for the diagnosis and treatment of cardiovascular diseases, often requiring intravascular stents. The region has a significant prevalence of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and other conditions that require stent implantation. Factors such as a sedentary lifestyle, poor dietary habits, and the aging population contribute to this high incidence. And also the region has been at the forefront of technological advancements in the field of medical devices, including intravascular stents. Many leading stent manufacturers and research institutions are in the region, driving innovation and product development. North American healthcare systems tend to adopt new medical technologies and treatments relatively early, contributing to a larger market share for innovative stent products, such as drug-eluting stents and bioresorbable stents. The presence of well-established health insurance systems in North America helps patients access and afford stent procedures. This insurance coverage encourages the adoption of stents as a treatment option.
Recent Developments
- In June 2024, Royal Philips, a global leader in health technology, announced the first implantation of the Duo Venous Stent System, an implantable medical device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). This follows the system's premarket approval (PMA) from the U.S. Food and Drug Administration (FDA).
Key Market Players
- BostonScientific Corporation
- Medtronic plc.
- TerumoMedical Corporation
- Abbott Laboratories Inc.
- BIOTRONIK SE & Co. KG
- Stryker Corporation
- MicroportScientific Corporation
- StentysS.A.
- HELLMAN & FRIEDMAN LLC
- B. BraunSE
| By Type | By Product | By End-Use | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy